The 2nd International Post-Tuberculosis Symposium
- 17 - 19 April 2023
- STIAS Institute, Stellenbosch, South Africa
'Life After TB'
The 2nd International Post-Tuberculosis Symposium
- 17 - 19 April 2023
- STIAS Institute, Stellenbosch, South Africa
'Life After TB'
The Symposium
Three Days of Powerful Talks and Workshops
Background
The World Health Organisation (WHO) estimates that approximately 54 million people survived TB between 2000 and 2017 alone.
There is increasing evidence of long-term respiratory complications following TB in a proportion of these patients, preventing them from returning to their normal lives. Patients can suffer from airflow obstruction, restrictive and fibrotic defects, bronchiectasis, and aspergillomas amongst other conditions. With chronic obstructive pulmonary disease (COPD) being the third leading cause of death worldwide, the problem of post-TB chronic respiratory disorders could be substantial.
In addition to the physiological and anatomical consequences, people who have survived TB often suffer significant economic and psychological consequences, which the international literature is starting to recognise. Despite emerging evidence, there is still a lack of international guidelines and recommendations on the follow-up of patients beyond the cure of TB. While WHO’s Global Action Plan on non-communicable diseases recommends incorporating screening for chronic respiratory disease in TB clinics, the WHO End TB Strategy neglects post-TB respiratory disorders.
Aims and Objectives
-
Advocacy
To increase global awareness of post-TB sequelae, and to empower TB affected communities -
Knowledge
Update knowledge on post-TB life and illness, and identify research priorities -
Networking
To build research collaborations. To setup concrete plans for research and advocacy -
Consensus
Highlight the need to embed Lung Health Outcomes in Clinical TB Trials
The Symposium
Three Days of Powerful Talks and Workshops
Background
The World Health Organisation (WHO) estimates that approximately 54 million people survived TB between 2000 and 2017 alone.
There is increasing evidence of long-term respiratory complications following TB in a proportion of these patients, preventing them from returning to their normal lives. Patients can suffer from airflow obstruction, restrictive and fibrotic defects, bronchiectasis, and aspergillomas amongst other conditions. With chronic obstructive pulmonary disease (COPD) being the third leading cause of death worldwide, the problem of post-TB chronic respiratory disorders could be substantial.
In addition to the physiological and anatomical consequences, people who have survived TB often suffer significant economic and psychological consequences, which the international literature is starting to recognise. Despite emerging evidence, there is still a lack of international guidelines and recommendations on the follow-up of patients beyond the cure of TB. While WHO’s Global Action Plan on non-communicable diseases recommends incorporating screening for chronic respiratory disease in TB clinics, the WHO End TB Strategy neglects post-TB respiratory disorders.
Aims and Objectives
-
Advocacy
To increase global awareness of post-TB sequelae, and to empower TB affected communities -
Knowledge
Update knowledge on post-TB life and illness, and identify research priorities -
Networking
To build research collaborations. To setup concrete plans for research and advocay -
Consensus
The need to embed Lung Health Outcomes in Clinical TB Trials
Welcome Letter
Dear Delegate
On behalf of the Steering Committee, I would like to extend a warm invitation to join us for the 2nd International Post-Tuberculosis Symposium at the STIAS Institute in Stellenbosch from 17-19 April 2023.
This multidisciplinary Symposium draws together key opinions and thought leaders in the field of post-tuberculosis outcomes, together with patients, clinicians, researchers, basic scientists, epidemiologists, and stakeholders.
At the three-day Symposium, global experts will give State of the Art Presentations on various aspects of life after tuberculosis. In addition, 10 workshops spanning the breadth of life and outcomes after tuberculosis will be held, during which you will be able to participate in discussions where priority knowledge gaps in the field are identified and consensus is needed to move the post-tuberculosis agenda forward.
We are very much looking forward to your attendance and participation at the Symposium.
For any further questions or assistance, please see the website www.post-tb-symposium.com or contact me directly.
Yours truly,
Welcome Letter
Dear Delegate
On behalf of the Steering Committee, I would like to extend a warm invitation to join us for the 2nd International Post-Tuberculosis Symposium at the STIAS Institute in Stellenbosch from 17-19 April 2023.
This multidisciplinary Symposium draws together key opinions and thought leaders in the field of post-tuberculosis outcomes, together with patients, clinicians, researchers, basic scientists, epidemiologists, and stakeholders.
At the three-day Symposium, global experts will give State of the Art Presentations on various aspects of life after tuberculosis. In addition, 10 workshops spanning the breadth of life and outcomes after tuberculosis will be held, during which you will be able to participate in discussions where priority knowledge gaps in the field are identified and consensus is needed to move the post-tuberculosis agenda forward.
We are very much looking forward to your attendance and participation at the Symposium.
For any further questions or assistance, please see the website www.post-tb-symposium.com or contact me directly.
Yours truly,
Steering Committee
- Brian Allwood (Co-Chair - SA)
- Marieke van der Zalm (Co-Chair - SA)
- Rebecca Nightingale (Secretary - UK)
- Anthony Byrne (Australia / Peru)
- Rafael Durand (Peru)
- James Johnston (Canada)
- Gautam Kalyatanda (India / USA)
- Olga Mashedi (Kenya)
- Kevin Mortimer (UK)
- Obianuju Ozoh (Nigeria)
- Andrea Rachow (Germany)
- Ingrid Schoeman (SA - Patient Advocate)
- Goodman Makanda (SA - Patient Advocate)
Congress Venue
STIAS Institute, Stellenbosch, South Africa
The Stellenbosch Institute for Advanced Study invests in experts who work across disciplinary borders to tackle issues ranging from health equity to complexity theory, and the effects of race to quantum information. In this age of tumultuous change, the development of a long-term view and a critical mass of expertise on a broad range of issues is crucial to the well-being of future generations.